Catalyst Wire Dossier Catalyst Wire Dossier

Grass Pollen Allergoid

· Allergopharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Grass Pollen Allergoid, covering 2014-06-05 to 2014-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis [Phase 3]

See pricing